Arrowhead Pharmaceuticals Inc. buy HC Wainwright
Start price
13.07.23
/
50%
€30.89
Target price
13.07.24
€80.49
Performance (%)
-26.48%
Price
09:30
€22.65
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -26.48%. This prediction currently runs until 13.07.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -0.825% | -0.825% |
iShares Core DAX® | -0.654% | 1.989% |
iShares Nasdaq 100 | 0.903% | 5.664% |
iShares Nikkei 225® | -0.740% | -1.363% |
iShares S&P 500 | -0.013% | 3.020% |
Comments by HC_Wainwright for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by HC_Wainwright for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.12
13.05.24
13.05.24
€83.32
13.05.25
13.05.25
12.57%
09:30
09:30
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.61
08.02.24
08.02.24
€83.48
08.02.25
08.02.25
-20.83%
09:30
09:30
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.39
10.08.23
10.08.23
€81.59
10.08.24
10.08.24
-14.17%
09:30
09:30